Worswick S - Search Results

1

Dupilumab in Dermatology: Potential for Uses Beyond Atopic Dermatitis.

Maloney NJ, Tegtmeyer K, Zhao J, Worswick S. Maloney NJ, et al. Among authors: worswick s. J Drugs Dermatol. 2019 Oct 1;18(10):S1545961619P1053X. J Drugs Dermatol. 2019. PMID: 31603635

2

Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation.

Maloney NJ, Hisaw LD, Worswick S. Maloney NJ, et al. Among authors: worswick s. Dermatol Ther. 2017 Nov;30(6). doi: 10.1111/dth.12559. Epub 2017 Oct 15. Dermatol Ther. 2017. PMID: 29034547

3

Type I pityriasis rubra pilaris treated with tumor necrosis factor inhibitors, ustekinumab, or secukinumab: A review.

Maloney NJ, Hisaw LD, Worswick S. Maloney NJ, et al. Among authors: worswick s. J Am Acad Dermatol. 2018 Sep;79(3):585-587. doi: 10.1016/j.jaad.2018.02.063. Epub 2018 Mar 5. J Am Acad Dermatol. 2018. PMID: 29518460 Review. No abstract available.

4

Development of alopecia in patients treated with dupilumab.

Maloney NJ, Worswick S, Cheng K. Maloney NJ, et al. Among authors: worswick s. Dermatol Ther. 2019 May;32(3):e12869. doi: 10.1111/dth.12869. Epub 2019 Mar 18. Dermatol Ther. 2019. PMID: 30834653 No abstract available.

5

Patient experiences with biologics and apremilast in pityriasis rubra pilaris: A patient survey.

Maloney NJ, Kim MM, Nguyen KA, Hisaw LD, Worswick S. Maloney NJ, et al. Among authors: worswick s. Dermatol Ther. 2019 Sep;32(5):e13060. doi: 10.1111/dth.13060. Epub 2019 Aug 18. Dermatol Ther. 2019. PMID: 31397958 No abstract available.

6

Neutrophilic dermatoses as adverse effects of checkpoint inhibitors: A review.

Ravi V, Maloney NJ, Worswick S. Ravi V, et al. Among authors: worswick s. Dermatol Ther. 2019 Sep;32(5):e13074. doi: 10.1111/dth.13074. Epub 2019 Sep 4. Dermatol Ther. 2019. PMID: 31444856 Review.

7

Stevens-Johnson syndrome and toxic epidermal necrolysis-like reactions to checkpoint inhibitors: a systematic review.

Maloney NJ, Ravi V, Cheng K, Bach DQ, Worswick S. Maloney NJ, et al. Among authors: worswick s. Int J Dermatol. 2020 Jun;59(6):e183-e188. doi: 10.1111/ijd.14811. Epub 2020 Feb 13. Int J Dermatol. 2020. PMID: 32052409

8

Overlap between hemophagocytic lymphohistiocytosis and drug reaction and eosinophilia with systemic symptoms: a review.

Yang JJ, Lei DK, Ravi V, Maloney NJ, Crew A, Worswick S. Yang JJ, et al. Among authors: worswick s. Int J Dermatol. 2020 Sep 21. doi: 10.1111/ijd.15196. Online ahead of print. Int J Dermatol. 2020. PMID: 32964443 Review.

9

Characterizing Disease Features and Other Medical Diagnoses in Patients With Pityriasis Rubra Pilaris.

Halper K, Wright B, Maloney NJ, Kim MM, Ravi V, Worswick S, Lei DK. Halper K, et al. Among authors: worswick s. JAMA Dermatol. 2020 Dec 1;156(12):1373-1374. doi: 10.1001/jamadermatol.2020.3426. JAMA Dermatol. 2020. PMID: 32965475 Free PMC article.

10

Sweet syndrome as an adverse reaction to tyrosine kinase inhibitors: A review.

Yang JJ, Maloney NJ, Nguyen KA, Worswick S, Smogorzewski J, Bach DQ. Yang JJ, et al. Among authors: worswick s. Dermatol Ther. 2021 Jan;34(1):e14461. doi: 10.1111/dth.14461. Epub 2020 Nov 5. Dermatol Ther. 2021. PMID: 33112465 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters